Journal of Cancer Research and Immuno-Oncology
Open Access

Latest updates in Cancer and Immuno-oncology

Xiaowei Liu^{* *}Correspondence: Xiaowei Liu, Center for Infectious Disease and Vaccinology, The Biodesign Institute, USA, Email:

Author info »

I am pleased to introduce Journal of Cancer Research and Immuno-oncology (JCRIO), a rapid peer reviewed Journal which has key concerns over the Cancer research by exploring the best patient oriented cancer research and by promoting these findings both directly as research outcomes and in practice oriented formats of direct application in day to-day situations. I am glad to announce our upcoming Volume 6, Issue 3 of the journal and all issues of volume 6 were published on scheduled time during the year of 2020. The Journals aims to flourish and to maintain the standards in research and cancer diagnosis provide platform and opportunity to present recent discoveries and developments in the field of cancer research thus help in promoting Cancer, Oncology research and so it is much useful for readers, Research scholars and health care professionals to enhance the patient care.

Journal of Cancer Research and Immuno-oncology publishes significant and up-to-date articles within the fields of Cancer Research and Immuno-oncology. Journal of Cancer Research and Immuno-oncology is a timely resource of cancer and immuno- oncology latest updates. The journal is established in 2015 and now published 9 issues; three issues in a year. Journal of Cancer Research and Immuno-Oncology is having International Standard Serial Number (ISSN) of 2684-1266.

With the cooperation of the senior and associate editors, we have created a set of practices and an environment that encourages the delivery of quality reviews in a timely fashion. These policies include the Expedited reviews. Manuscripts are reviewed at the editor-in- chief, senior editor, and associate editor levels before being sent out to reviewers. At any of these stages an editor may reject the manuscript or send it back to the author for improvement. This gets a response to the authors much more quickly and preserves reviewing resources for other manuscripts. In the case of immediate revision, authors are given a chance to provide an enhanced manuscript to the eventual reviewers, thus increasing the odds of acceptance. Associate editors complete a short evaluation for each reviewer on each manuscript. This process reminds reviewers that they are responsible for timely, high-quality reviews and also serves to help identify future associate editor candidates.

All scientific manuscripts including editorials are subjected to peer review process. At many instances members of the editorial board also prefer to submit their articles. In fact, JCRIO encourages editorial board members to actively contribute. However, no special privileges are given to anyone. The editorial team consisting of associate editors and assistant editors are involved in the entire article cycle starting from submission to final recommendation. The entire review process is carefully structured so as to minimize possibility of bias.

Journal of Cancer Research and Immuno-oncology functions on principles of scientific excellence, publication ethics and transparency. It makes the authors easy to submit their articles through the online manuscript submission and review system managed by Longdom as the publisher. Journal follows strict guidelines related to publication ethics and conflict of interests.

Main aims and objectives of this journal is to publish more and more quality articles of research, review, short commentary, mini reviews, case reports etc which will be very useful for the readers. We would like publish more articles including latest updates and current trending topics related to cancer and immune-oncology.

In future we would like to publish more articles which are trending and innovative with different therapies including the treatment of cancer. We would like to invite articles which show new discoveries of COVID-19 vaccine and current chemotherapy and immunotherapies used in the treatment plan of cancer. COVID-19 which is pandemic and current hot topic and its discovery of vaccination is challenging for all the countries. We would like to invite articles which show the effect of corona virus on the cancer patients and the treatment given to them.

We would like to thank authors, Editorial board members, reviewers and readers, only because of them Journal of Cancer Research and Immuno-oncology became very successful with good number of quality research articles. The objective of JCRIO is to publish up- to-date, high-quality and original research papers alongside relevant and insightful reviews. This journal aspires to be vibrant, engaging and accessible, and at the same time integrative and challenging.